Products


Anti-Schizophrenia Drug Approved by The FDA

FDA has confirmed lumateperone tosylate (Caplyta™, Intra-Cellular Therapies) anti-schizophrenia drug for the therapy of schizophrenia in grown-up sufferers. Lumateperone is an atypical antipsychotic. The precise…



Remdesivir Therapy: Clinical Researches

Results from a cohort study of 53 patients hospitalized with critical complications of the coronavirus infection 2019 (COVID-19) who were satisfied with investigational antiviral redeliver…



COVID-19 Test From Abbott

The Food and Drug Administration (FDA) granted the emergency use for quick COVID-19 test from Abbott Laboratories. The test was designed for pharmacists services, critical…